Trump-touted antibody cocktail holds therapeutic promise for COVID-19 patients, as clinical trials continue
By Natalie Eilbert Medill Reports When President Donald Trump stood before Americans and called his bout with COVID-19 this fall a “blessing in disguise,” he touted Regeneron as the new pharmaceutical “cure” the world has been desperate for. His doctors at Walter Reed Hospital expedited the experimental antibody treatment he received and combined the antibody […]
